These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29383855)

  • 21. Tetrahymena thermophila and Candida albicans group I intron-derived ribozymes can catalyze the trans-excision-splicing reaction.
    Dotson PP; Johnson AK; Testa SM
    Nucleic Acids Res; 2008 Sep; 36(16):5281-9. PubMed ID: 18684993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site.
    Ryu KJ; Lee SW
    J Microbiol; 2004 Dec; 42(4):361-4. PubMed ID: 15650696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribozyme gene therapy: applications for molecular medicine.
    Lewin AS; Hauswirth WW
    Trends Mol Med; 2001 May; 7(5):221-8. PubMed ID: 11325634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating group I intron catalytic efficiency in mammalian cells.
    Long MB; Sullenger BA
    Mol Cell Biol; 1999 Oct; 19(10):6479-87. PubMed ID: 10490588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional repair of a mutant chloride channel using a trans-splicing ribozyme.
    Rogers CS; Vanoye CG; Sullenger BA; George AL
    J Clin Invest; 2002 Dec; 110(12):1783-9. PubMed ID: 12488428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells.
    Jones JT; Lee SW; Sullenger BA
    Nat Med; 1996 Jun; 2(6):643-8. PubMed ID: 8640554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribozyme and peptide-nucleic acid-based gene therapy.
    Phylactou LA
    Adv Drug Deliv Rev; 2000 Nov; 44(2-3):97-108. PubMed ID: 11072108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
    Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
    Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the substrate specificity of a group I intron ribozyme.
    Zarrinkar PP; Sullenger BA
    Biochemistry; 1999 Mar; 38(11):3426-32. PubMed ID: 10079089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering a family of synthetic splicing ribozymes.
    Che AJ; Knight TF
    Nucleic Acids Res; 2010 May; 38(8):2748-55. PubMed ID: 20299341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA.
    Lan N; Rooney BL; Lee SW; Howrey RP; Smith CA; Sullenger BA
    Mol Ther; 2000 Sep; 2(3):245-55. PubMed ID: 10985955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging Tetrahymena ribozyme splicing activity in single live mammalian cells.
    Hasegawa S; Jackson WC; Tsien RY; Rao J
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14892-6. PubMed ID: 14645710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell detection of trans-splicing ribozyme in vivo activity.
    Hasegawa S; Choi JW; Rao J
    J Am Chem Soc; 2004 Jun; 126(23):7158-9. PubMed ID: 15186136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
    Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
    Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of tumor-targeting trans-splicing ribozyme for cancer treatment.
    Lee SW; Jeong JS
    Methods Mol Biol; 2014; 1103():83-95. PubMed ID: 24318888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
    Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
    Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.